WHO ICTRP trial

Prospective Evaluation of erectile function after Collagenase Therapy in…

DRKS00010450 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00010450
Public title Prospective Evaluation of erectile function after Collagenase Therapy in Patietens with Peyronies Disease
Scientific title Prospective Evaluation of erectile function after Collagenase Therapy in Patietens with Peyronies Disease - ERECT
Primary sponsor Universitätsklinik Freiburg, Abteilung für Urologie Sektion Andrologie
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type observational
Countries Germany
Conditions N48.6;Induratio penis plastica;N48.6
Interventions Group 1: Following therapy is intended: - 1 injection every 4 weeks, totaling 3 injections - between injections patients are advised to perform penile modeling on a daily basis (10min) - Injection dosage: 0,25ml/injection Xiapex - Injection…
Registration date Mar 5, 2016
Target size 75
Secondary IDs 6751
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations